Fluoxetine Pellets And Powder Suppliers & Bulk Manufacturers
Available Forms: Pellets: Oral, slow-release formulations for capsule manufacturing; Powder: Used in pharmaceutical manufacturing for capsule or suspension fabrication
Available Strengths: Supplied as high-purity API in pellet and powder forms
Reference Brands: Prozac and Generic fluoxetine
Category:
Active Pharmaceutical Ingredient
Fluoxetine pellets and powder work by selectively inhibiting serotonin reuptake in the brain, increasing serotonin levels. Benefits include improved mood, reduced anxiety, and support in treating depression, OCD, and other mental health conditions. It promotes emotional stability and enhances quality of life when used as prescribed.
Fluoxetine Pellets and Powder is available in Pellets: Oral, slow-release formulations for capsule manufacturing; Powder: Used in pharmaceutical manufacturing for capsule or suspension fabrication
and strengths such as Supplied as high-purity API in pellet and powder forms.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Fluoxetine Pellets and Powder is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Fluoxetine Pellets and Powder can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Fluoxetine pellets and powder are regulated in the EU and US, with dossiers demonstrating safety, efficacy, and manufacturing quality in accordance with GMP standards. In the US, FDA approval involves clinical validation, safety testing, and GMP compliance. In the EU, CE marking certifies conformity with MDR standards. These products undergo validation, stability testing, and audits, supported by detailed documentation including safety profiles, pharmacological data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to high-quality fluoxetine API, supporting the production of antidepressant formulations and mental health therapies globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing